These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6234254)

  • 1. Detection of bone metastases in patients with breast cancer.
    Coombes RC; Dearnaley DP; Buckman R; Jones JM; Ormerod MG; Sloane JP; Powles TJ; Gazet JC; Ford HT; Neville AM
    Invasion Metastasis; 1982; 2(3):177-84. PubMed ID: 6234254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
    Gulenchyn KY; Papoff W
    Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of breast carcinoma metastases in bone: relative merits of X-rays and skeletal scintigraphy.
    Perez DJ; Powles TJ; Milan J; Gazet JC; Ford HT; McCready VR; MacDonald JS; Coombes RC
    Lancet; 1983 Sep; 2(8350):613-6. PubMed ID: 6136757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is bone scanning of value in patients with breast cancer?
    Spencer GR; Khan M; Bird C; Seymour R; Brown TR; Collins CD
    Acta Chir Scand; 1981; 147(4):247-8. PubMed ID: 6459704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone scanning after marrow biopsy: concise communication.
    Tyler JL; Powers TA
    J Nucl Med; 1982 Dec; 23(12):1085-7. PubMed ID: 7143090
    [No Abstract]   [Full Text] [Related]  

  • 6. [Two cases of bone metastases from primary hepatoma].
    Kurooka N; Tokumoto Y; Itoh J; Bando H; Morimoto K; Matsumori S; Okauchi S; Shimazu H
    Rinsho Hoshasen; 1984 Jan; 29(1):131-4. PubMed ID: 6234411
    [No Abstract]   [Full Text] [Related]  

  • 7. Negative bone scintigraphy with diffuse osteoblastic breast carcinoma metastases.
    Brown B; Laorr A; Greenspan A; Stadalnik R
    Clin Nucl Med; 1994 Mar; 19(3):194-6. PubMed ID: 8033466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of pre-treatment and follow-up skeletal scintigraphy in operable breast cancer.
    Pauwels EK; Heslinga JM; Zwaveling A
    Clin Oncol; 1982 Mar; 8(1):25-32. PubMed ID: 6280915
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone scanning in Ewing's sarcoma.
    Nair N
    J Nucl Med; 1985 Apr; 26(4):349-52. PubMed ID: 3156974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tarsal metastases from breast carcinoma: a case report and review of the literature].
    Sandomenico F; Iovino M; Cappabianca S; Del Vecchio W; Procaccini E
    Radiol Med; 1996 Mar; 91(3):306-8. PubMed ID: 8628947
    [No Abstract]   [Full Text] [Related]  

  • 11. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
    Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
    Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of the 99mTc-polyphosphonate bone scan in renal carcinoma.
    Clyne CA; Frank JW; Jenkins JD; Smart CJ
    Br J Urol; 1983 Apr; 55(2):174-5. PubMed ID: 6220752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.
    Pollen JJ; Witztum KF; Ashburn WL
    AJR Am J Roentgenol; 1984 Apr; 142(4):773-6. PubMed ID: 6230903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium - 99M methylene-diphosphonate bone scan: mechanisms and clinical applications.
    Tan KF; Chang CH
    Singapore Med J; 1982 Apr; 23(2):61-72. PubMed ID: 6215712
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of 99Tcm-labelled MDP and DMAD bone scanning agents in patients with advanced breast cancer.
    Coleman RE; Meier CA; Rubens RD; Fogelman I
    Nucl Med Commun; 1988 Jul; 9(7):481-5. PubMed ID: 3173907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of non-staging skeletal scintigraphy in breast cancer.
    Kunkler IH; Merrick MV
    Clin Radiol; 1986 Nov; 37(6):561-2. PubMed ID: 3098492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bone imaging in the detection of skeletal metastasis].
    Shi QX
    Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):196-8. PubMed ID: 2612332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxyproline excretion in the detection of occult bone metastases from breast cancer.
    Rowse AD; Morrison MJ; Scott PH; Banks AJ; Roginski C
    Oncology; 1982; 39(5):287-91. PubMed ID: 7099511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of 99mTc-methylene diphosphonate scintigraphy of patients with lung cancer].
    Abe M; Ohde R; Ogata T; Kawaguchi S; Kikuchi K; Kawai T; Matsuzawa K; Takanoshi H
    Rinsho Hoshasen; 1982 Jun; 27(6):621-5. PubMed ID: 6292553
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
    Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
    Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.